All In MedTech

Device Trial Radar · NCT04860986

A Repeatability and Reproducibility Study of the EarliPoint™ Device

A Repeatability and Reproducibility Study of the EarliPoint™ Device in Pediatric Subjects 16-30 Months of Age

Last checked: Nov 19, 2026Latest source record: Nov 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

May 7, 2021

Primary completion

Nov 17, 2021

Study completion Nov 17, 2021

Sponsor

Lead sponsor
EarliTec Diagnostics, IncNot on our public-company list
Sponsor type
Industry
First posted
Apr 27, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 16 months, up to 30 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a prospective randomized repeatability and reproducibility (R\&R) study of the EarliPoint DeviceTM in pediatric subjects 16-30 months of age. The study will enroll subjects who are both clinically-positive and clinically-negative for ASD. The study will be conducted at a single center in the US. The Study consists of a screening period in order to review the subject's medical history to determine subject eligibility, followed by a device administration period during which subjects will undergo testing with the EarliPoint Devices and Expert Clinician Diagnosis (ECD) procedures to determine if they are clinically-positive or clinically-negative for ASD.

Conditions

  • Autism Spectrum Disorder (ASD)

Interventions

  • EarliPointDevice

    EarliPoint is a non-invasive diagnostic device for ASD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The EarliPoint Device repeatabilityTime frame: Anticipated in about 6 months
  2. The EarliPoint Device reproducibilityTime frame: Anticipated in about 6 months
  3. The repeatability variance of the underlying EarliPoint DeviceTime frame: Anticipated in about 6 months

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Emory University

    Atlanta, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.